1. China Stocks

  2. •

    Health technology

  3. •

    Medical specialties
Angelalign Technology Inc.

Angelalign Technology Inc.

78.80
HKD
-1.25
(-1.56%)
10.18BMarket Cap
Mar 25Next Earn
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
0.06
0.08
0.12
0.21
1.1
1.25
1.6
2.19
- -
Basic EPS, GAAP
0.01
0.01
0.02
0.05
0.19
0.04
0.07
0.17
- -
Free Cash Flow per Basic Share
0.01
0.04
0.05
0.04
0.04
0.04
-0.07
0.3
- -
Dividend per Share
- -
- -
0.01
0.02
0.15
0.09
0.14
0.11
- -
Book Value per Share
0.02
0.04
0.07
0.49
3.07
2.79
2.79
2.92
2.92
Tangible Book Value per Share
0.02
0.03
0.06
0.48
3.06
2.65
2.64
2.79
2.79
Basic Weighted Avg Shares
166
166
166
148
167
168
168
169
170
Sales/Revenue/Turnover
10
13
19
31
184
210
269
370
- -
Operating Margin (%)
15.77
12.98
23.87
23.78
14.33
-0.76
-1.66
8.51
- -
Depreciation Expense
- -
1
1
1
9
12
16
18
- -
Net Income, GAAP
1
1
4
7
31
8
12
28
- -
Effective Tax Rate (%)
22.19
19.92
21.07
14.01
15.33
20.32
14.15
16.93
- -
Profit Margin (%)
12.23
10.66
18.45
22.48
16.84
3.59
4.51
7.68
- -
Working Capital
3
4
8
75
444
401
364
333
333
LT Debt
- -
- -
- -
- -
2
5
7
9
9
Total Equity
3
6
12
82
517
481
480
504
504
Return on Invested Capital (%)
- -
23.87
33.55
13.86
8.54
-0.61
1.08
4.93
- -
Return on Capital (%)
- -
28.25
38.39
14.99
10.36
1.81
3.15
6.3
- -
Return on Common Equity (%)
- -
29.36
39.55
15.06
10.33
1.52
2.56
5.84
- -

Capital Structure

USD

•

in mil. unless spec.
Dec'24
Jun'25
Dec'25
ST Debt
7
84
7
LT Borrowings
- -
1
1
LT Finance Leases
7
6
9
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
170
171
171
Market Capitalization
1,289
1,230
1,308

Working Capital

USD

•

in mil. unless spec.
Dec'24
Jun'25
Dec'25
Total Current Assets
492
559
501
Cash, Cash Equivalents & STI
437
488
429
Accounts Receivable, Net
14
33
30
Inventories
18
17
17
Total Current Liabilities
128
201
168
Payables & Accruals
- -
- -
- -
ST Debt
7
84
7
Deferred Revenue
- -
- -
- -

Growth Rates

USD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
226.17%
4.98%
Free Cash Flow
- -
-166.99%
-543%
Net Income, GAAP
- -
111.71%
134.74%
Sales/Revenue/Turnover
- -
125.96%
37.76%
Total Cash Common Dividend
- -
186.74%
-23.06%

Semi-annual Revenue

USD

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
210
2024
- -
- -
269
2025
- -
- -
370

Semi-annual Earnings Per Share

USD

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
0.04
2024
- -
- -
0.07
2025
- -
- -
0.17

Semi-annual Dividends Per Share

USD

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
0.09
2024
- -
- -
0.14
2025
- -
- -
0.11

Company Description

Company Profile APIChatGPT
CEO
Jiezhang Hu
Full Time Employees
4,312
Sector
Health technology
Industry
Medical specialties
Address
Building No. 7, KIC Business Center Shanghai SH China
IPO Date
Jun 16, 2021
Website
angelalign.com
Similar Companies
Intuitive Surgical, Inc. (NASDAQ:ISRG)
Boston Scientific Corporation (NYSE:BSX)
Thermo Fisher Scientific Inc (NYSE:TMO)
Illumina, Inc. (NASDAQ:ILMN)
Abbott Laboratories (NYSE:ABT)
GRAIL, Inc. (NASDAQ:GRAL)
Business
Angelalign Technology Inc. (6699.HK) is an investment holding company that researches, designs, manufactures, markets, and sells clear aligner treatment solutions primarily in the People's Republic of China and internationally. The company offers a portfolio of custom-made removable clear orthodontic aligners, including Angel Aligner Pro and Angel Aligner Select for comprehensive adult treatments; Angel Aligner KiD for early orthodontic intervention from prevention to treatment in children; Angel Aligner Retainer for post-treatment retention; Angel Aligner Classic; and COMFOS aligners tailored for varying treatment complexities and patient demographics; it also provides orthodontics and cosmetic dentistry services through its network of dental clinics, as well as intraoral scanners. Angelalign Technology serves dental professionals, orthodontists, and patients seeking aesthetic orthodontic care, with operations focused on the Asia-Pacific region including China and expanding globally. Founded in 2003 and headquartered at Building No. 7, KIC Business Center in Shanghai, China, the company is a subsidiary of CareCapital Orthotech Limited. Recent developments include a strategic investment in LuxCreo in 2025 to co-develop advanced 3D printing materials for direct-printed clear aligners; the launch of a new U.S. manufacturing facility, the KiD aligner system, and a new retainer solution; partnerships with the American Association of Orthodontists Foundation (AAOF) and Dental Monitoring; and increased investments in international sales, marketing, clinical support, ex-China treatment centers and manufacturing sites, intellectual property strategy, compliance, and data security infrastructure as part of its first-half 2025 results reporting a 33.1% year-over-year revenue increase.